. Author manuscript; available in PMC: 2019 Jul 12.

Published in final edited form as: Am J Health Behav. 2009 Nov-Dec;33(6):650–660. doi: 10.5993/ajhb.33.6.3

Table 2.

Prevalence of Cancer Screening Among Asian American Subgroups

Cancer Screening	Total	Chinese (n=718)	Vietnamese (n=305)	Korean (n=289)	Cambodian (n=291 )	χ²
Breast Cancer-Mammogram^a
Never screened	33.6	20.10	28.36	30.23	78.52
Noncompliance (>2yrs)	22.8	22.28	33.58	27.91	10.07
Within 12 mo	43.6	57.63	38.06	41.86	11.41	187.5^*
Cervical Cancer-Pap Test^b
Never screened	37.7	27.95	33.33	35.71	75.61
Noncompliance (>2yrs)	23.8	21.48	35.71	31.87	9.76
Within 12 mo	38.6	50.57	30.95	32.42	14.63	160.2^*
Prostate Cancer^c
N ever screened	78.2	56.72	88.00	78.85	96.97
Noncompliance (>2yrs)	7.5	17.91	1.00	5.77	1.0 I
Within 12 mo	14.3	25.37	11.00	15.38	2.02	66.9^*
Liver Cancer-HBV^d
Never screened	71.4	62.12	79.67	67.82	89.35
Screened	28.6	37.88	20.33	32.18	10.65	88.3^*
Colorectal Cancerd^e
Never screened	79.1	65.27	86.15	74.47	94.88
Noncompliance (>2yrs)	7.9	14.15	3.08	8.5]	2.79
Within 12 mo	13.0	20.58	10.77	17.02	2.33	78.7^*
Routine Health Exam^e
Never screened	11.8	9.18	13.24	34.69	5.19
Noncompliance (>2)’rs)	32.0	19.64	15.98	14.29	75.76
Within 12 mo	56.2	71.17	70.78	51.02	19.05	319.8^*

Note.

For women 40+

For women 18+

For men 50+

For men and women 18+

For men and women 50+

Colorectal cancer screening refers to colonoscopy, fecal occult blood test (FOBT) or any CRC screening

P<.0001